Journal article
2021 Asia‐Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout
International Journal of Rheumatic Diseases, Vol.25(1), pp.7-20
2022
Abstract
Background
Gout is the most prevalent inflammatory arthritis in the Asia-Pacific region and worldwide. This clinical practice guideline (CPG) aims to provide recommendations based on systematically obtained evidence and values and preferences tailored to the unique needs of patients with gout and hyperuricemia in Asia, Australasia, and the Middle East. The target users of these guidelines are general practitioners and specialists, including rheumatologists, in these regions.
Methods
Relevant clinical questions were formulated by the Steering Committee. Systematic reviews of evidence were done, and certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation methodology. A multi-sectoral consensus panel formulated the final recommendations.
Results
The Asia-Pacific League of Associations for Rheumatology Task Force developed this CPG for treatment of gout with 3 overarching principles and 22 recommendation statements that covered the treatment of asymptomatic hyperuricemia (2 statements), treatment of acute gout (4 statements), prophylaxis against gout flare when initiating urate-lowering therapy (3 statements), urate-lowering therapy (3 statements), treatment of chronic tophaceous gout (2 statements), treatment of complicated gout and non-responders (2 statements), treatment of gout with moderate to severe renal impairment (1 statement), and non-pharmacologic interventions (5 statements).
Conclusion
Recommendations for clinically relevant scenarios in the management of gout were formulated to guide physicians in administering individualized care.
Details
- Title
- 2021 Asia‐Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout
- Authors/Creators
- J.P.P. Lorenzo (Author/Creator)M.H.M.Z. Sollano (Author/Creator)E.O. Salido (Author/Creator)J. Li‐Yu (Author/Creator)S.A. Tankeh‐Torres (Author/Creator)I.A.R. Wulansari Manuaba (Author/Creator)M.M. Rahman (Author/Creator)B.J. Paul (Author/Creator)M.Y. Mok (Author/Creator)M. de Silva (Author/Creator)P. Padhan (Author/Creator)A.L. Lim (Author/Creator)M. Marcial (Author/Creator)J.J. Vicera (Author/Creator)S.A. Haq (Author/Creator)S. Salman (Author/Creator)C.K. Liyanage (Author/Creator)H.I. Keen (Author/Creator)C. Yew Kuang (Author/Creator)J.C‐C Wei (Author/Creator)R.Y. Hellmi (Author/Creator)C.E. Chan (Author/Creator)W. Louthrenoo (Author/Creator)
- Publication Details
- International Journal of Rheumatic Diseases, Vol.25(1), pp.7-20
- Publisher
- John Wiley & Sons Australia, Ltd
- Identifiers
- 991005545365507891
- Copyright
- © 2021 Asia Pacific League of Associations for Rheumatology
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
151 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.281 Auto-inflammatory Diseases
- 1.281.1192 Gout
- Web Of Science research areas
- Rheumatology
- ESI research areas
- Clinical Medicine